Abbott Secures CE Mark for Dual Glucose-Ketone Sensing Technology

Abbott (ABT) has secured the CE Mark for its new technology. This is the world's first dual glucose-ketone sensing system. It is designed specifically for diabetes management. The technology allows for simultaneous monitoring of two markers. This development marks a significant medical advancement. It provides users with more comprehensive health data. The CE Mark enables the technology's use in relevant markets. This innovation aims to improve patient monitoring capabilities.